'Rbv' diaporamas de présentation

Sofosbuvir ( Sovaldi )

Sofosbuvir ( Sovaldi ). Prepared by: David Spach, MD & H. Nina Kim, MD Last Updated: July 14, 2015. Sofosbuvir ( Sovaldi ). Background and Dosing. Sofosbuvir ( Sovaldi ). Approval Status : FDA approved December 6, 2013

2.06k views • 194 slides

How to Optimize Treatment of non G1 Patients

Luncheons PHC Paris January 31, 2012. How to Optimize Treatment of non G1 Patients. Alessandra Mangia S. Giovanni Rotondo ITALY. March 14, 2011. 49 years old man, BMI: 28 HCV diagnosed in 1998 - previous iv drug and alcohol user - genotype 3, HCVRNA:410.000 IU/ml

504 views • 50 slides

HCV 2014 and b eyond the i nterferon era

HCV 2014 and b eyond the i nterferon era. Patrick M. Horne, MSN, ARNP, FNP-BC Assistant Director of Hepatology Clinical Research Division of Gastroenterology, Hepatology and Nutrition University of Florida Health. Disclosures and Off-label Discussion.

556 views • 37 slides

Standard Interferon vs. Pegylated Interferon

317 views • 30 slides

DYNAMIC CAPABILITIES: WHAT ARE THEY?

DYNAMIC CAPABILITIES: WHAT ARE THEY?. ???????? ?????????? ?????????? 2011/04/01. ?? dynamic capabilities ????????? RBV ????????????? RBV ?????????????????????????????????????????????????????????????????????????. DYNAMIC CAPABILITIES. ???

551 views • 13 slides

The problem statement of RBridge edge group state synchronization draft-hao-trill-rb-syn-00

243 views • 9 slides